Knowing that ANG2 is currently being investigated as a potential target for anti-angiogenic tumor therapy60, it is tempting to speculate that anti-ANG2 approaches might also have therapeutic value in HHT. Here, ANGPT2 is linked to hereditary hemorrhagic telangiectasia.